Raoel Maan (R Maan)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Mesenchymal Stem Cells

Hepatitis C Virus Infection

Pulmonary Arterial Hypertension

Patient Reported Outcomes

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Raoel Maan, Milan J Sonneveld
Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test. Alimentary pharmacology & therapeutics 53 (8) (2021)
M van Tilborg, F I Lieveld, E J Smolders, K J van Erpecum, C T M M de Kanter, Raoel Maan, M van der Valk, J E Arends, A S M Dofferhoff, H Blokzijl, M Bijmolen, J P H Drenth, R J de Knegt, D M Burger, null null
Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals. Alimentary pharmacology & therapeutics 46 (9) (2017)
Raoel Maan, S H Al Marzooqi, J S Klair, J Karkada, O Cerocchi, M Kowgier, S M Harrell, K D Rhodes, H L A Janssen, Jordan J Feld, A Duarte-Rojo
The frequency of acute kidney injury in patients with chronic hepatitis C virus infection treated with sofosbuvir-based regimens. Alimentary pharmacology & therapeutics 46 (1) (2017)
Raoel Maan, Jordan J Feld, Andrés Duarte-Rojo
Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply. Alimentary pharmacology & therapeutics 46 (3) (2017)